Oleanolic acid-derived triterpenoids with dual TGR5 agonistic and RORγ inverse agonistic activity
The Takeda G protein-coupled receptor 5 (TGR5) and the retinoid-related orphan receptor γ (RORγ) are key regulators of metabolic and immune pathways. This makes them attractive targets for developing anti-inflammatory and metabolic therapeutics. In this study, we designed and synthesised a series of oleanolic acid-derived triterpenoid derivatives to explore their potential as dual modulators of these receptors. The focus of the structural modifications was on the double bond, C-3 substitution, and A-ring rearrangements in order to investigate their impact on biological activity and establish structure-activity relationships within the pentacyclic triterpene scaffold. Biological evaluation using CRE-luciferase reporter assays identified oleanolic acid (1), oleanonic acid (5), and compounds 7 and 8 as TGR5 agonists with concentration-dependent activities. Oleanolic acid (1) and the newly identified seco-derivative 8 displayed the most favourable potency and efficacy profiles. Gal4-RORγ reporter assays demonstrated inverse agonistic activity for oleanolic acid (1) and compounds 7 and 8. Although 7 and 8 exhibited lower potency than 1, both retained pronounced inhibitory efficacy, indicating that substantial scaffold rearrangement remains compatible with RORγ modulation. A resazurin conversion assay showed no evidence of cytotoxicity under the conditions tested, supporting that the observed receptor effects were not attributable to general cytotoxicity. Molecular modelling and Nwat-MMGBSA calculations supported the experimental findings and emphasized the role of conserved buried water molecules in stabilising ligand-receptor interactions in both targets. Overall, these findings identify oleanolic acid-derived triterpenoids as promising scaffolds for dual TGR5/RORγ modulation and provide valuable insights for the future development of multitarget-directed ligands targeting inflammatory and metabolic disorders.
Authors
- Patrik F. Schwarz (ORCID: https://orcid.org/0000-0002-3093-4176)
- Verena Maria Dirsch (ORCID: https://orcid.org/0000-0002-9261-5293)
- Johannes Kirchmair (ORCID: https://orcid.org/0000-0003-2667-5877)
- Alexander F. Perhal (ORCID: https://orcid.org/0000-0003-3922-6333)
- Ioannis K. Kostakis (ORCID: https://orcid.org/0000-0002-9901-5223)
- Jorge Enrique Hernández González (ORCID: https://orcid.org/0000-0002-4770-8677)
- Maria Halabalaki (ORCID: https://orcid.org/0000-0001-5620-0165)
- Panagiota Stamou
- Justin Weal (ORCID: https://orcid.org/0009-0004-8911-7500)
- AL Skaltsounis
- Ya Chen (ORCID: https://orcid.org/0000-0001-5273-1815)
Institutions
- University of Vienna (AT)
- National and Kapodistrian University of Athens (GR)
- Universidade Estadual Paulista (Unesp) (BR)
Publication Details
- Journal
- RSC Medicinal Chemistry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1039/d6md00471g
- Primary Topic
- Natural product bioactivities and synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Austrian Science Fund
- Eidgenössische Technische Hochschule Zürich
- Ministério da Ciência, Tecnologia e Inovação
- Conselho Nacional de Desenvolvimento Científico e Tecnológico